H.L. Bock

1.5k total citations
46 papers, 1.2k citations indexed

About

H.L. Bock is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, H.L. Bock has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 20 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in H.L. Bock's work include Hepatitis Viruses Studies and Epidemiology (18 papers), Hepatitis B Virus Studies (12 papers) and Bacterial Infections and Vaccines (11 papers). H.L. Bock is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (18 papers), Hepatitis B Virus Studies (12 papers) and Bacterial Infections and Vaccines (11 papers). H.L. Bock collaborates with scholars based in Germany, Belgium and United Kingdom. H.L. Bock's co-authors include Carl Heinz Wirsing von König, H.-J. Schmitt, Ralf Clemens, H. Bogaerts, U. Klockmann, Yanee Hutagalung, J Weil, Nicholas J. White, Sasithon Pukrittayakamee and Hubert J. Schmitt and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

H.L. Bock

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.L. Bock Germany 18 728 399 345 249 240 46 1.2k
Pamela Rendi‐Wagner Austria 21 481 0.7× 704 1.8× 189 0.5× 379 1.5× 500 2.1× 39 1.3k
Edward Rothstein United States 19 793 1.1× 433 1.1× 511 1.5× 150 0.6× 77 0.3× 44 1.4k
F.A. Moraga Llop Spain 21 934 1.3× 315 0.8× 591 1.7× 122 0.5× 119 0.5× 143 1.4k
Jon E. Stek United States 23 1.2k 1.6× 321 0.8× 200 0.6× 132 0.5× 42 0.2× 49 1.5k
Lily Yin Weckx Brazil 15 1.1k 1.5× 353 0.9× 126 0.4× 107 0.4× 118 0.5× 53 1.6k
H.E. de Melker Netherlands 21 1.1k 1.5× 363 0.9× 587 1.7× 127 0.5× 98 0.4× 38 1.5k
M.A.E. Conyn-van Spaendonck Netherlands 23 1.3k 1.8× 597 1.5× 764 2.2× 81 0.3× 123 0.5× 47 1.9k
Heinz‐Josef Schmitt Germany 23 1.2k 1.6× 561 1.4× 344 1.0× 41 0.2× 177 0.7× 42 1.7k
Susan Hahné Netherlands 17 956 1.3× 265 0.7× 160 0.5× 404 1.6× 86 0.4× 40 1.2k
Maria Paulke‐Korinek Austria 17 186 0.3× 659 1.7× 88 0.3× 216 0.9× 366 1.5× 27 873

Countries citing papers authored by H.L. Bock

Since Specialization
Citations

This map shows the geographic impact of H.L. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.L. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.L. Bock more than expected).

Fields of papers citing papers by H.L. Bock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.L. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.L. Bock. The network helps show where H.L. Bock may publish in the future.

Co-authorship network of co-authors of H.L. Bock

This figure shows the co-authorship network connecting the top 25 collaborators of H.L. Bock. A scholar is included among the top collaborators of H.L. Bock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.L. Bock. H.L. Bock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaman, Khalequ, David A. Sack, Mohammad Yunus, et al.. (2009). Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine. 27(9). 1333–1339. 90 indexed citations
2.
Saha, Samir K., et al.. (2008). Seroprevalence of Hepatitis A Infection by Age Group and Socioeconomic Status in Bangladesh. International Journal of Infectious Diseases. 12. e101–e102. 2 indexed citations
3.
Müller, R., H.L. Bock, Ralf Clemens, & Wolfgang Jilg. (2008). Aktive Immunisierung gegen Hepatitis A: Vergleich verschiedener Impfschemata. DMW - Deutsche Medizinische Wochenschrift. 118(31). 1101–1104. 1 indexed citations
4.
Anh, Đặng Đức, Vũ Đình Thiểm, Yanee Hutagalung, et al.. (2008). Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants. International Journal of Infectious Diseases. 12. e147–e147. 5 indexed citations
5.
Knuf, Markus, Pirmin Habermehl, Jörg Faber, et al.. (2006). Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine. 24(27-28). 5627–5636. 13 indexed citations
6.
Phua, Kong Boo, Seng Hock Quak, S C Emmanuel, et al.. (2006). A short report on highlights of worldwide development of RIX4414: A Singaporean experience. Vaccine. 24(18). 3782–3783. 9 indexed citations
7.
Vos, Béatrice De, A. Delem, Karin Hardt, et al.. (2005). A short report on clinical evaluation of RIX4414: highlights of world-wide development. Vaccine. 24(18). 3777–3778. 9 indexed citations
8.
Awaidy, Salah Al, et al.. (2005). Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. Journal of Infection. 52(3). 202–206. 41 indexed citations
9.
Lolekha, Somsak, et al.. (2001). Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.. American Journal of Tropical Medicine and Hygiene. 64(3). 131–136. 135 indexed citations
10.
Bock, H.L., et al.. (2001). HIGHER ANTI‐HEPATITIS B RESPONSE WITH COMBINED DTPw‐HBV VACCINE COMPARED WITH SEPARATE ADMINISTRATION IN HEALTHY INFANTS AT 3, 4 AND 5 MONTHS OF AGE IN SLOVAKIA. International Journal of Clinical Practice. 55(3). 156–161. 9 indexed citations
11.
Kallinowski, B., H.L. Bock, Ralf Clemens, & Lorenz Theilmann. (1996). Immunogenicity and reactogenicity of a combined hepatitis A/B candidate vaccine: first results. Liver International. 16(4). 271–273. 14 indexed citations
13.
Schmitt, H. J., Anne Schuind, M Knuf, et al.. (1996). Acellular Pertussis Vaccines: The Rationale For An Efficacy Trial In Germany. The Journal of Infectious Diseases. 174(Supplement 3). S287–S290. 6 indexed citations
14.
König, Carl Heinz Wirsing von, et al.. (1995). Pertussis in adults: frequency of transmission after household exposure. The Lancet. 346(8986). 1326–1329. 180 indexed citations
15.
König, Carl Heinz Wirsing von, et al.. (1995). Symptoms and complications of pertussis in adults. Infection. 23(3). 139–142. 76 indexed citations
16.
Petersen, E. E., et al.. (1992). Hepatitis B and C in heterosexual patients with various sexually transmitted diseases. Infection. 20(3). 128–131. 24 indexed citations
17.
Hingst, V., et al.. (1992). Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. European Journal of Clinical Microbiology & Infectious Diseases. 11(4). 334–340. 38 indexed citations
18.
Kallinowski, B., K. Gmelin, B Kommerell, et al.. (1992). Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine — a randomized multicentre study with three consecutive vaccine lots. Vaccine. 10(8). 500–501. 6 indexed citations
19.
Theilmann, Lorenz, B. Kallinowski, K. Gmelin, et al.. (1992). Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. Vaccine. 10. S132–S134. 11 indexed citations
20.
Bock, H.L., et al.. (1990). A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine. 8(1). 22–24. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026